The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chronic pain, epilepsy, and inflammatory conditions.

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

For example, multiple hemp shop operators in Austin have told the Chronic that customers who buy CBD oil for therapeutic use ...

Novel research has revealed that adolescent vaping of current delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and ...

It’s not 4/20, but it may look like it in Denver with deals at dispensaries and social events across the Mile High City in ...

Catching up with Betty's Eddies Brand Ambassador Sara Rosenfield to discuss the brand's seasonal summer product and more.

Teen vaping habits are shifting toward stronger and more mysterious substances. Synthetic cannabinoids are rising fast — and ...

Teen vaping is changing fast — and not in a good way. A large national study found that more adolescents are vaping THC, CBD, ...

Novel research has revealed that adolescent vaping of current delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and ...

RSO is more than just another cannabis product. It’s a full-spectrum, whole-plant extract with a serious reputation – especially among people using it for therapeutic purposes. And that’s all a […] ...

This new research focuses on comparing the bioavailability of different cannabinoid formulations, taking a step forward in our understanding of medical cannabis.

This new research focuses on comparing the bioavailability of different cannabinoid formulations, taking a step forward in our understanding of medical cannabis. The study aimed to assess the ...